Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | Sodium borohydride | HCID 4311764 | — |
| Reactant | HCID 54362632 | HCID 54362632 | — |
| Solvent | Water | HCID 962 | — |
| Product | HCID 67560545 | HCID 67560545 | — |
Reaction Steps
To a mixture of 2.0 g (6.2 mmoles) of 1-(4-fluorostyryl)-4-methyl-7,8-methylenedioxy-5H-2,3-benzodiazepine prepared according to Example 86 and 10 ml of glacial acetic acid a solution of 3.0 g (79 mmoles) of sodium borohydride in 10 ml of water is added in small portions, while the temperature of the reaction mixture is kept below 35° C. The mixture is then stirred for further 2 hours and made alkaline by adding some sodium carbonate solution to it. The alkaline solution is extracted three times with 20 ml of ethyl acetate. The ethyl acetate phases are dried, evaporated and the evaporation residue is crystallized from ethanol. The crude product is purified by recrystallization from ethanol. Thus 1.39 g (69%) of substance pure on TLC is obtained. M.p.: 170-174° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05942506 |
|---|
| Source dataset | uspto-grants-1999_08 |
|---|
| ORD ID | ord-3035f0ceebef4c3bbd601c7aaaf740de |
|---|
| Source note | uspto-grants-1999_08 |
|---|